Cell Motil Cytoskeleton 53 : 2638
World J Urol 41:12211228 Yeh JA, Liu YC, Huang AH, Peng CC, Loh CH, Munir KM, Huang HK (2025) SGLT2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes: a cohort study and meta-analysis
Sarah Armstrong, a member of the AAP guideline committee, stated in a 2023 AAP press briefing: "We do not have the evidence to support pharmacotherapy with GLP-1 agonists below age 12, and clinicians should not extrapolate from adolescent data to younger children without trial-level safety evidence." The Endocrine Society's pediatric obesity guideline similarly restricts pharmacotherapy recommendations to adolescents aged 12 and older when lifestyle interventions have been insufficient [7]
It also restores memory, locomotion, and coordination
How dose escalation works in practice is worth confirming directly with the platform before subscribing
Dont overlook semaglutide side effects like depression